Key result
Statin use is linked to lower mortality in colorectal cancer but shows no relapse benefit.
Why the study?
Does statin use reduce all-cause and cancer-specific mortality in colorectal cancer patients?
Does statin use reduce all-cause and cancer-specific mortality in colorectal cancer patients?
Answers are grounded in this paper and cite their sources.
Statin use is associated with improved overall and cancer-specific survival in patients with colorectal cancer, though it does not significantly impact relapse-free or disease-free survival.
Statin use was associated with a reduction in ACM and CSM in CRC patients. However, the variances in RFS and DFS were not statistically significant. However, these findings should be interpreted cautiously due to substantial heterogeneity among some included studies.
No takes yet. Share an insight, caveat, or question.
Vahed et al. (2026) studied this question. Statin use was associated with reduced all-cause and cancer-specific mortality in colorectal cancer patients, but had no significant effect on relapse-free or disease-free survival.
Synapse has enriched 10 related papers. Consider them for comparative context: